Brevan Howard Capital Management LP

Position in MRNA — Moderna, Inc.

CIK 1512857 ST. HELIER, Y9

Position in MRNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,551,375

+$4,234,977 QoQ

Shares Held

89,594

+735.1% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brevan Howard Capital Management LP holds $135,070,881 across 172 Biotechnology names. MRNA ranks #5 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	81,570	$6,057,388
2	ASND	Ascendis Pharma A/S	26,200	$5,992,726
3	SNDX	Syndax Pharmaceuticals Inc	204,845	$4,785,179
4	TERN	Terns Pharmaceuticals, Inc.	88,596	$4,670,780
5	MRNA	Moderna, Inc. This page	89,594	$4,551,375
6	SLNO	Soleno Therapeutics Inc	135,621	$4,540,590
7	RARE	Ultragenyx Pharmaceutical Inc.	215,845	$4,521,951
8	INCY	Incyte Corp	46,448	$4,371,685

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,551,375	89,594	+735.1%	Shares	Defined	2026-05-15
2025-12-31	$316,398	10,729	+241.0%	Shares	Defined	2026-02-17
2024-06-30	$373,587	3,146	-98.0%	Shares	Defined	2024-08-14
2023-09-30	$16,216,530	157,000	0.0%	Shares	Defined	2023-11-14
2023-06-30	$19,075,500	157,000	-39.6%	Shares	Defined	2023-08-14
2023-03-31	$39,930,800	260,000	+13.0%	Shares	Defined	2023-05-15
2022-12-31	$41,312,600	230,000	-54.0%	Shares	Defined	2023-02-14
2022-09-30	$59,125,000	500,000	+78.6%	Shares	Defined	2022-11-14
2022-06-30	$39,998,000	280,000	+409.1%	Shares	Defined	2022-08-15
2022-03-31	$9,474,300	55,000	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.